Showing 1 - 8 results of 8 for search 'C Cattaneo', query time: 0.04s
Refine Results
-
1
Records of Chrysomya albiceps in Northern Italy: an ecological and forensic perspective by S Vanin, L Caenazzo, A Arseni, G Cecchetto, C Cattaneo, M Turchetto
Published 2009-07-01
Article -
2
The effects of safinamide according to gender in Chinese parkinsonian patients by M. T. Pellecchia, M. Picillo, M. C. Russillo, V. Andreozzi, C. Oliveros, C. Cattaneo
Published 2023-11-01
Article -
3
-
4
P11 COMBINED DIFFUSION WEIGHTED WHOLE BODY MRI (DW-MRI) AND MULTIPARAMETRIC FLOW CYTOMETRY (MFC) EVALUATION FOR MINIMAL RESIDUAL DISEASE DETECTION IN MULTIPLE MYELOMA PATIENTS: CON... by A. Belotti, R. Ribolla, C. Crippa, M. Chiarini, V. Giustini, S. Ferrari, A. Peli, C. Cattaneo, A. Roccaro, B. Frittoli, L. Grazioli, G. Rossi, A. Tucci
Published 2023-05-01
Article -
5
P1450: AUTOLOGOUS STEM CELL TRANSPLANTATION INDUCES HIGHER LEVEL OF EXHAUSTED T-CELLS IN DLBCL PATIENTS BEFORE LEUKAPHERESIS FOR CAR-T CELL THERAPY. by M. Farina, M. Chiarini, C. Almici, A. Beghin, E. Accorsi Buttini, A. Galvagni, E. Ferrari, A. Bianchetti, F. Zuccalà, S. Piva, I. Volonghi, L. Poli, D. Moratto, A. Leoni, F. Re, K. Bosio, S. Bernardi, N. Polverelli, A. Turra, E. Morello, C. Cattaneo, A. Lanfranchi, M. Malagola, D. Brugnoni, A. Re, D. Russo
Published 2022-06-01
Article -
6
S281: PRIOR EXPOSURE TO IMMUNOSUPPRESSIVE AGENTS AND COMORBIDITIES ARE ASSOCIATED WITH WORSE OUTCOMES OF SARS-COV2 INFECTION IN PH-NEG CHRONIC MYELOPROLIFERATIVE NEOPLASMS: RESULTS... by M. Marchetti, J. Salmanton-García, S. El-Ashwah, M. V. Sacchi, F. Marchesi, Z. Ráčil, M. Hanakova, G. Zambrotta, L. Verga, F. Passamonti, F. Itri, J. Van Doesum, S. Martìn-Pérez, A. López-García, J. Dávila-Valls, R. Cordoba, G. Abu-Zeinah, G. Dragonetti, C. Cattaneo, V. Bonuomo, L. Prezioso, A. Glenthøj, F. Farina, R. Duarte, O. Blennow, O Cornely, L. Pagano
Published 2022-06-01
Article -
7
P517: PROSPECTIVE MULTICENTRIC STUDY ON INFECTIOUS COMPLICATIONS AND CLINICAL OUTCOME IN 230 UNFIT AML PATIENTS TREATED IN FIRST-LINE WITH HYPOMETHYLATING AGENTS ALONE OR IN COMBIN... by A. Candoni, M. Piccini, D. Lazzarotto, V. Bonuomo, M. Dargenio, M. Riva, L. Mellillo, C. Papayannidis, M. Stulle, G. Dragonetti, M. I. Del Principe, C. Cattaneo, C. Pasciolla, R. De Marchi, M. Delia, M. C. Tisi, M. E. Zannier, G. Nadali, M. Sciumè, A. Spadea, C. Sartor, D. Griguolo, E. Buzzatti, C. M. Basilico, C. Sarlo, A. L. Piccioni, R. Cairoli, A. Olivieri, L. Pagano
Published 2022-06-01
Article -
8
S280: B-CELL MALIGNANCIES TREATED WITH TARGETED DRUGS AND SARS-COV-2 INFECTION. A EUROPEAN HEMATOLOGY ASSOCIATION SURVEY (EPICOVIDEHA) by M. S. Infante, J. Salmanton-García, A. Fernandez-Cruz, F. Marchesi, Z. RÁČIL, M. Hanakova, O. Jaksic, B. Weinbergerova, C. Besson, R. Duarte, F. Itri, T. VALKOVIĆ, A. Busca, A. Guidetti, A. GLENTHØJ, G. Collins, V. Bonuomo, U. Sili, G. Seval, M. Machado, A. Lopez-Garcia, R. Cordoba, O. Blennow, G. Abu-zeinah, S. Lemure, A. Kulasekararaj, I. Falces-Romero, C. Cattaneo, O. A. Cornely, J.-A. Hernandez-Rivas, L. Pagano
Published 2022-06-01
Article